Susquehanna International Group, LLP Guardant Health, Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 51,834 shares of GH stock, worth $2.11 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,834
Previous 74,054
30.01%
Holding current value
$2.11 Million
Previous $1.7 Million
6.77%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding GH
# of Institutions
347Shares Held
120MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$491 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$458 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$262 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$222 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$213 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.16B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...